Market Cap

AC Immune SA Market Capitalization:

$208.2 Million

USD as of July 1, 2025

business AC Immune SA Company Profile

AC Immune SA Main Stock Listing

NASDAQ: ACIU

Market Capitalization History of AC Immune SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of AC Immune SA market cap

Date Market Cap YoY Change
Jan. 1, 2025 $267.1 M -45.92%
Jan. 1, 2024 $494.0 M 141.73%
Jan. 1, 2023 $204.4 M -48.42%
Jan. 1, 2022 $396.2 M -26.09%
Jan. 1, 2021 $536.0 M -35.63%
Jan. 1, 2020 $832.7 M 125.49%
Jan. 1, 2019 $369.3 M -69.16%
Jan. 1, 2018 $1.20 B 11.15%
Jan. 1, 2017 $1.08 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

AC Immune SA Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

AC Immune SA has the following listings and related stock indices.


Stock: NASDAQ: ACIU

Stock: FSX: IMR

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.